Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells
Related Experiment Video
Updated: Feb 12, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Jingyao Chen1, Yanfeng Zhu1, Weiwei Zhang1
1Department of Public Health, Chengdu Medical College, 783 Xindu Avenue, Xindu, Chengdu, Sichuan, 610500, People's Republic of China.
Background:
We have previously demonstrated the anticancer effect of anthocyanins. In this study, we explored the biological activities of delphinidin, the most common of the anthocyanidin monomers, that were related to autophagy in HER-2 positive breast cancer MDA-MB-453 and BT474 cells.
Methods:
The effects of various doses of delphinidin on the proliferation and apoptosis of MDA-MB-453 and BT474 cells were analysed. Autophagy was identified as a critical factor that influenced chemotherapy, and the autophagic mechanism in delphinidin-treated cells was investigated. The autophagy inhibitors, 3-MA and BA1, were used to analyse the effects of autophagy inhibition.
Results:
Delphinidin inhibited proliferation, promoted apoptosis, and induced autophagy in MDA-MB-453 and BT474 cells in a dose-dependent manner. The inhibition of autophagy enhanced the delphinidin-induced apoptosis and antiproliferative effect in both HER-2 positive breast cancer cells. In addition, delphinidin induced autophagy via suppression of the mTOR signalling pathway and activation of the AMPK signalling pathway in HER-2 positive breast cancer cells.
Conclusions:
Collectively, the results showed that delphinidin induced apoptosis and autophagy in HER-2 positive breast cancer cells and that autophagy was induced via the mTOR and AMPK signalling pathways. The suppression of autophagy promoted the anticancer effects of delphinidin.
Insights
Delphinidin, an anthocyanin, inhibits growth and promotes apoptosis in HER-2 positive breast cancer cells by inducing autophagy. Suppressing autophagy enhances delphinidin
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Anthocyanins exhibit anticancer properties.
- This study focuses on delphinidin, a common anthocyanidin, and its role in autophagy within HER-2 positive breast cancer cells (MDA-MB-453 and BT474).
Purpose of the Study:
- To investigate the biological activities of delphinidin related to autophagy in HER-2 positive breast cancer.
- To analyze the effects of delphinidin on cancer cell proliferation and apoptosis.
- To elucidate the autophagic mechanism and its influence on chemotherapy.
Main Methods:
- Assessed delphinidin's impact on proliferation and apoptosis in MDA-MB-453 and BT474 cells.
- Investigated the autophagic mechanism in delphinidin-treated cells.
- Utilized autophagy inhibitors (3-MA and BA1) to evaluate the effects of autophagy inhibition.
Main Results:
- Delphinidin demonstrated dose-dependent inhibition of proliferation, promotion of apoptosis, and induction of autophagy in cancer cells.
- Inhibition of autophagy potentiated delphinidin's antiproliferative and pro-apoptotic effects.
- Delphinidin induced autophagy through mTOR pathway suppression and AMPK pathway activation.
Conclusions:
- Delphinidin induces apoptosis and autophagy in HER-2 positive breast cancer cells via mTOR and AMPK signaling.
- Autophagy suppression enhances the anticancer efficacy of delphinidin.
- Delphinidin shows potential as an anticancer agent for HER-2 positive breast cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Other Glycolytic Pathways
Respiration Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...

